Exscientia Stock (NASDAQ: EXAI) stock price, news, charts, stock research, profile.
Open | $5.47 |
Close | $5.11 |
Volume / Avg. | 338.76K / 519.16K |
Day Range | 5.02 - 5.52 |
52 Wk Range | 3.86 - 9.12 |
Market Cap | $640.76M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 6.15% |
Days to Cover | 8.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exscientia (NASDAQ:EXAI) through any online brokerage.
Other companies in Exscientia’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Replimune Group (NASDAQ:REPL), Fate Therapeutics (NASDAQ:FATE) and Emergent BioSolutions (NYSE:EBS).
There is no analysis for Exscientia.
Exscientia has a consensus price target of $11.80.
The stock price for Exscientia (NASDAQ: EXAI) is $5.0703 last updated July 24, 2024 at 6:22 PM EDT.
There are no upcoming dividends for Exscientia.
Exscientia’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Exscientia.
Exscientia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.